一月 2026
- Home
- PCI Synthesis
一月 2026的PCI Synthesis市场份额分析
we are full-service cgmp active pharmaceutical ingredients (api) contract manufacturing company of nce & drug products
PCI Synthesis(包含公司地区分支机构)
查看更多网站流量和参与度信息- pcisynthesis.com
PCI Synthesis收入截至 一月 2026为 25M - 50M
PCI Synthesis主要域名产生的收入
3 年中PCI Synthesis主要域名的收入
PCI Synthesis主要域名的收入
PCI Synthesis热门域名的总访问量
了解PCI Synthesis市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
无数据可显示
无数据可显示
PCI Synthesis热门域名的平均访问时长
分析PCI Synthesis参与度指标。
过去 3 个月的平均访问时长
无数据可显示
无数据可显示
PCI Synthesis热门域名的平均页面浏览量
了解PCI Synthesis如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
无数据可显示
无数据可显示
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
PCI Synthesis 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Pcisynthesis hired Bob Huang as Managing Director for North America on Sep 14th '21.Seqens CDMO North America (formerly known as PCI Synthesis, Inc.), a pharmaceutical manufacturer of new chemical entities (NCEs), active pharmaceutical ingredients (APIs) and other specialty chemical products, today announced that Bob Huang has joined as Managing Director for North America.
九月 14, 2021阅读更多
新闻Pcisynthesis hired Jean-Noel David as Managing Director for North America on Sep 15th '20.Newburyport, MA & Ecully, FRANCE, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Seqens CDMO North America (formerly known as PCI Synthesis, Inc.), a pharmaceutical manufacturer of new chemical entities (NCEs), active pharmaceutical ingredients (APIs), and other specialty chemical products, today announced that it has appointed Jean-Noel David as Managing Director for North America.
九月 15, 2020阅读更多
新闻Pcisynthesis receives award awards in each of the six major award categories.Although PolyCarbon Industries, Inc. won awards in each of the six major award categories, and in addition received six other awards in specialty categories, PolyCarbon Industries, Inc. consider Reliability to be the among the most vital to sponsors.
八月 3, 2019阅读更多
查看 PCI Synthesis 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。